9-methoxycamptothecin from nothapodytes foetida induces apoptosis in murine sarcoma s180 cells

Zeitschrift fur Naturforschung - Section C Journal of Biosciences

Volumn 66 C, Issue 9-10, 2011, Pages 471-476

  Liao, Na ^a   Zhang, Peng ^a   Ao, Mingzhang ^a   Wang, Jing ^a   Shi, Yueyuan ^a   Yu, Longjiang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Bcl 2 family protein; Camptothecin derivative; Intrinsic apoptotic pathway

Indexed keywords

MURINAE; NOTHAPODYTES FOETIDA;

EID: 80055088038     PISSN: 09395075     EISSN: None     Source Type: Journal    
DOI: 10.1515/znc-2011-9-1006     Document Type: Article

References (24)

1. Buolamwini J. K. (1999), Novel anticancer drug discovery. Curr. Opin. Chem. Biol. 3, 500-509.
2. Chen T. C., Su S., Fry D., and Liebes L. (2003), Combination therapy with irinotecan and protein kinase C inhibitors in malignant glioma. Cancer 97, 2363-2373.
3. Duprez L., Wirawan E., Vanden Berghe T., and Vandenabeele P. (2009), Major cell death pathways at a glance. Microbes Infect. 11, 1050-1062.
4. Govindachari T. R. and Viswanathan N. (1972), Alkaloids of Mappia foetida. Phytochemistry 11, 3529-3531.
5. Hsiao H. Y., Cheng T. J., Yang G. M., Huang I. J., and Chen R. L. C. (2008), Determination of camptothecins in DMSO extracts of Nothapodytes foetida by direct injection capillary electrophoresis. Phytochem. Anal. 19, 136-140.
6. Huang M., Gao H. Y., Chen Y., Zhu H., Cai Y. J., Zhang X. W., Miao Z. H., Jiang H. L., Zhang J., Shen H. W., Lin L. P., Lu W., and Ding J. (2007), Chimmitecan, a novel 9-substituted camptothecin, with improved anticancer pharmacologic profiles in vitro and in vivo. Clin. Cancer Res. 13, 1298-1307.
7. Ju D. S., Kim M. J., Bae J. H., Song H. S., Chung B. S., Lee M. K., Kang C. D., Lee H. S., Kim D. W., and Kim S. H. (2007), Camptothecin acts synergistically with imatinib and overcomes imatinib resistance through Bcr-Abl independence in human K562 cells. Cancer Lett. 252, 75-85.
8. Lauria A., Ippolito M., and Almerico A. M. (2007), Molecular docking approach on the topoisomerase I inhibitors series included in the NCI anti-cancer agents mechanism database. J. Mol. Model. 13, 393-400.
9. Miettinen S. and Ylikomi T. (2009), Concomitant exposure of ovarian cancer cells to docetaxel, CPT-11 or SN-38 and adenovirus-mediated p53 gene therapy. Anti-Cancer Drugs 20, 589-600.
10. Pommier Y., Jaxel C., Heise C. R., Kerrigan D., and Kohn K. W. (1991), Structure-Activity Relationship of Topoisomerase I Inhibition by Camptothecin Derivatives: Evidence for the Existence of a Ternary Complex. Oxford University Press, New York.
11. Portugal J., Bataller M., and Mansilla S. (2009), Cell death pathways in response to antitumor therapy. Tumori 94, 409-421.
12. Srinivas K.V.N.S. and Das B. (2003), 9-Methoxy-20-O-acetylcamptothecin, a minor new alkaloid from Nothapodites foetida. Biochem. Syst. Ecol. 31, 85-87.
13. Togano T., Sasaki M., Watanabe M., Nakashima M., Tsuruo T., Umezawa K., Higashihara M., Watanabe T., and Horie R. (2009), Induction of oncogene addiction shift to NF-kappa B by camptothecin in solid tumor cells. Biochem. Biophys. Res. Commun. 390, 60-64.
14. Van Hattum A. H., Pinedo H. M., Schluper H. M., Hausheer F. H., and Boven E. (2000), New highly lipophilic camptothecin BNP1350 is an effective drug in experimental human cancer. Int. J. Cancer 88, 260-266.
15. Wang W., Guo Q. L., You Q. D., Zhang K., Yang Y., Yu J., Liu W., Zhao L., Gu H. Y., Hu Y., Tan Z., and Wang X. T. (2006), The anticancer activities of wogonin in murine S180 both in vitro and in vivo. Biol. Pharm. Bull. 29, 1132-1137.
16. Wang L. M., Li Q. Y., Zu Y. G., Fu Y. J., Chen L. Y., Lv H. Y., Yao L. P., and Jiang S. G. (2008), Anti-proliferative and pro-apoptotic effect of CPT13, a novel camptothecin analog, on human colon cancer HCT8 cell line. Chem.-Biol. Interact. 176, 165-172.
17. Wiebe J. P., Beausoleil M., Zhang G. H., and Cialacu V. (2010), Opposing actions of the progesterone metabolites, 5α-dihydroprogesterone (5αP) and 3α-dihydroprogesterone (3αHP) on mitosis, apoptosis, and expression of Bcl-2, Bax and p21 in human breast cell lines. J. Steroid Biochem. Mol. Biol. 118, 125-132.
18. Wu T. S., Chan Y. Y., Leu Y. L., Chern C. Y., and Chen C. F. (1996), Nothapodytes A and B from Nothapodytes foetida. Phytochemistry 42, 907-908.
19. Wu S. F., Hsieh P. W., Wu C. C., Lee C. L., Chen S. L., Lu C. Y., Wu T. S., Chang F. R., and Wu Y. C. (2008), Camptothecinoids from the seeds of Taiwanese Nothapodytes foetida. Molecules 13, 1361-1371.
20. Yang J., Liu X., Bhalla K., Kim C. N., Ibrado A. M., Cai J. Y., Peng T. I., Jones D. P., and Wang X. D. (1997), Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275, 1129-1132.
21. Yang B. F., Lu Y. J., and Wang Z. G. (2009), MicroRNAs and apoptosis: implications in the molecular therapy of human disease. Clin. Exp. Pharmacol. Physiol. 36, 951-960.
22. Youle R. J. and Strasser A. (2008), The Bcl-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 9, 47-59.
23. Zeng S., Liu W., Nie F. F., Zhao Q., Rong J. J., Wang J., Tao L., Qi Q., Lu N., Li Z. Y., and Guo Q. L. (2009), A new flavonoid with a piperazine substitution, shows antitumor effects in vivo and in vitro. Biochem. Biophys. Res. Commun. 385, 551-556.
24. Zhou B. N., Hoch J. M., Johnson R. K., Mattern M. R., Eng W. K., Ma J., Hecht S. M., Newman D. J., and Kingston D. G. I. (2000), Use of compare analysis to discover new natural product drugs: Isolation of camptothecin and 9-methoxycamptothecin from a new source. J. Nat. Prod. 63, 1273-1276.